Assyro AI

Orange Book product · Generic (ANDA)

FOSAPREPITANT DIMEGLUMINE

FOSAPREPITANT DIMEGLUMINE

Generic (ANDA)ANDA 210625TE APRX EUGIA PHARMA
View FOSAPREPITANT DIMEGLUMINE familyOpen on FDA Orange Book

At a glance

Jan 12, 2021

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 12, 2021

    5 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

FOSAPREPITANT DIMEGLUMINE

Strength

EQ 150MG BASE/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

AP

Application

ANDA 210625

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of FOSAPREPITANT DIMEGLUMINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo